Evidence map›Paper›PMID 38931883›Full record

ArticlePharmaceutics2024

Solitary and Synergistic Effects of Different Hydrophilic and Hydrophobic Phospholipid Moieties on Rat Behaviors.

Shuhei Kikuchi, Yugo Iwasaki, Mina Yoshioka, Kodai Hino, Shin-Ya Morita, Ryu Tada, Yasuhiro Uchimura, Yoshinori Kubo, Tomoya Kobayashi, Yusuke Kinoshita and 6 more

Abstract read
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Pharmaceutics · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Shuhei KikuchiDivision of Anatomy and Cell Biology, Department of Anatomy, Shiga University of Medical Science, Otsu 520-2192, Shiga, Japan.
Yugo IwasakiCollege of Bioscience and Biotechnology, Chubu University, Kasugai 487-8501, Aichi, Japan.ORCID 0000-0003-2784-9269
Mina YoshiokaDivision of Anatomy and Cell Biology, Department of Anatomy, Shiga University of Medical Science, Otsu 520-2192, Shiga, Japan.
Kodai HinoDivision of Anatomy and Cell Biology, Department of Anatomy, Shiga University of Medical Science, Otsu 520-2192, Shiga, Japan.
Shin-Ya MoritaDepartment of Pharmacotherapeutics, Shiga University of Medical Science, Otsu 520-2192, Shiga, Japan.ORCID 0000-0003-4079-707X
Ryu TadaMolecular Engineering Institute, Shiga University of Medical Science, Otsu 520-2192, Shiga, Japan.
Yasuhiro UchimuraDivision of Anatomy and Cell Biology, Department of Anatomy, Shiga University of Medical Science, Otsu 520-2192, Shiga, Japan.
Yoshinori KuboDivision of Anatomy and Cell Biology, Department of Anatomy, Shiga University of Medical Science, Otsu 520-2192, Shiga, Japan.ORCID 0000-0002-3316-1607
Tomoya KobayashiDivision of Anatomy and Cell Biology, Department of Anatomy, Shiga University of Medical Science, Otsu 520-2192, Shiga, Japan.
Yusuke KinoshitaGraduate School of Life Sciences, Ritsumeikan University, Kusatsu 525-8577, Shiga, Japan.
Masahiro HayashiDepartment of Marine Biology and Environmental Science, Faculty of Agriculture, University of Miyazaki, Miyazaki 889-2192, Miyazaki, Japan.
Yoshio FurushoDepartment of Chemistry, Shiga University of Medical Science, Otsu 520-2192, Shiga, Japan.
Hitoshi TamiakiGraduate School of Life Sciences, Ritsumeikan University, Kusatsu 525-8577, Shiga, Japan.ORCID 0000-0003-4797-0349
Hiroaki IshiyamaDivision of Anatomy and Cell Biology, Department of Anatomy, Shiga University of Medical Science, Otsu 520-2192, Shiga, Japan.
Minoru KurodaDivision of Anatomy and Cell Biology, Department of Anatomy, Shiga University of Medical Science, Otsu 520-2192, Shiga, Japan.
Jun UdagawaDivision of Anatomy and Cell Biology, Department of Anatomy, Shiga University of Medical Science, Otsu 520-2192, Shiga, Japan.ORCID 0000-0002-6573-9434

Funding

Japan Society for the Promotion of Science JP 20K07918
6 · The paper itself

Abstract

Glycerophospholipids have hydrophobic and hydrophilic moieties. Previous studies suggest that phospholipids with different moieties have different effects on rodent behavior; however, the relationship between chemical structures and behavioral effects remains unclear. To clarify the functions of phospholipid moieties, we injected male rats with phospholipids with different moieties and conducted behavioral tests. Exploratory activity was reduced by phosphatidylethanolamine (PE)(18:0/22:6) but not PE(18:0/18:0) or PE(18:0/20:4). Conversely, exploratory activity was increased by plasmanyl PE(16:0/22:6), which harbors an alkyl-ether linkage, but not by phosphatidylcholine (PC)(16:0/22:6) or plasmanyl PC(16:0/22:6). Docosahexaenoic acid (DHA)(22:6) and an alkyl-ether linkage in PE were thus postulated to be involved in exploratory activity. Anxiety-like behavior was reduced by plasmenyl PC(18:0/20:4), which harbors a vinyl-ether linkage, but not by PC(18:0/20:4) or plasmanyl PC(18:0/20:4), suggesting the anxiolytic effects of vinyl-ether linkage. The activation of social interaction was suppressed by PE(18:0/18:0), PE(18:0/22:6), PC(16:0/22:6), plasmanyl PE(16:0/22:6), and plasmanyl PC(16:0/22:6) but not by PE(18:0/20:4), plasmenyl PE(18:0/20:4), or plasmanyl PC(18:0/22:6). DHA may suppress social interaction, whereas arachidonic acid(20:4) or a combination of alkyl-ether linkage and stearic acid(18:0) may restore social deficits. Our findings indicate the characteristic effects of different phospholipid moieties on rat behavior, and may help to elucidate patterns between chemical structures and their effects.

Indexed as

anxietyether linkagefatty acidslocomotor activityphosphatidylcholinephosphatidylethanolaminesociability

Identifiers

PMID38931883
PMCPMC11207216

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.